Use of Continuous Glucose Monitoring Devices Among People Living With Type 1 Diabetes in Kenya: A Three-arm Pragmatic Randomized Study on the Effectiveness, Feasibility, Acceptability, and Cost.
The study, sponsored by the Foundation for Innovative New Diagnostics, aims to evaluate the effectiveness, feasibility, acceptability, and cost of continuous versus intermittent use of CGMs among individuals with Type 1 diabetes in Kenya. Given the increasing prevalence of diabetes in low- and middle-income countries (LMICs) and the potential for CGMs to improve patient outcomes, this study could inform clinical models for integrating CGMs into standard diabetes care. The findings may enhance market access for CGM manufacturers and influence pricing strategies, particularly in LMICs where cost is a significant barrier. The collaboration with local diabetes management centers and charitable trusts suggests a strong commitment to addressing healthcare disparities, which may enhance the sponsor's reputation and foster partnerships in future initiatives.
Indication: Type 1 Diabetes
Modality: medical device
Target: Continuous Glucose Monitoring Devices (CGMs) for diabetes management
Sponsor: Foundation for Innovative New Diagnostics, Switzerland
Source URL: ClinicalTrials.gov
Source updated: Detailed source ingestion pending
Ingested: Jul 02, 2026
Model: trialsignal-ai-v1
Validation: validated
Matched by target_normalized: Continuous Glucose Monitoring Devices (CGMs) for diabetes management
View original source fields
Condition raw: Type 1 Diabetes
Condition normalized: Type 1 Diabetes
Modality raw: medical device
Modality normalized: medical device
Target raw: Continuous Glucose Monitoring Devices (CGMs) for diabetes management
Target normalized: Continuous Glucose Monitoring Devices (CGMs) for diabetes management